APA (7th ed.) Citation

N, A., L, B., JC, F., WM, R., RE, M., & MA, G. (2026). Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach. Drug design, development and therapy, 20, 593126. https://doi.org/10.2147/DDDT.S593126

Chicago Style (17th ed.) Citation

N, Atatreh, Bustanji L, Ferreira JC, Rabeh WM, Mahgoub RE, and Ghattas MA. "Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach." Drug Design, Development and Therapy 20 (2026): 593126. https://doi.org/10.2147/DDDT.S593126.

MLA (9th ed.) Citation

N, Atatreh, et al. "Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach." Drug Design, Development and Therapy, vol. 20, 2026, p. 593126, https://doi.org/10.2147/DDDT.S593126.